An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening—but the anxiously awaited new data leaves unclear how much difference that might make in people’s lives.
An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening—but the anxiously awaited new data leaves unclear how much difference that might make in people’s lives.
